Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03466879 · ClinicalTrials.gov registry record
A User Study of SYNUS Pain Relief Made by Tivic Health Systems
A clinical trial of Sinus; Inflammation, sponsored by Tivic Health Systems.
- Completed
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT03466879: Completed study of Sinus; Inflammation, sponsored by Tivic Health Systems.
NCT03466879 is a study of Sinus; Inflammation that has completed, run by Tivic Health Systems. The registered enrollment target is 72 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03466879, a study of Sinus; Inflammation, has completed, sponsored by Tivic Health Systems.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
Demonstrate the ability of subjects suffering from sinus pain to self-treat with the SYNUS Pain Relief device and to obtain pain relief compared to a sham/placebo device.
Primary Outcome
Average decrease in pain score of the SYNUS device is greater than the average decrease is pain score for the sham/placebo device.
Conditions Studied
Interventions
- DEVICE SYNUS Pain Relief device
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2018-07-21 |
What the finished NCT03466879 record still lists
NCT03466879 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 1 condition, with Sinus; Inflammation appearing as the primary indexed condition, and to 1 intervention - of which SYNUS Pain Relief device is the first listed.
NCT03466879 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03466879 about?
NCT03466879 is a clinical study titled "A User Study of SYNUS Pain Relief Made by Tivic Health Systems". Demonstrate the ability of subjects suffering from sinus pain to self-treat with the SYNUS Pain Relief device and to obtain pain relief compared to a sham/placebo device.
What is the current status of trial NCT03466879?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2018-02-02. Estimated completion is 2018-07-21.
What conditions does trial NCT03466879 study?
This clinical trial studies the following conditions: Sinus; Inflammation.
What interventions are being tested in trial NCT03466879?
The interventions under investigation include: SYNUS Pain Relief device (DEVICE).
Who is sponsoring clinical trial NCT03466879?
This trial is sponsored by Tivic Health Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03466879 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI